Twice-daily spray packed with powerful antibodies has blocked flu infection in animals and proved safe in early human tests ...
Sales of Johnson & Johnson’s esketamine-based nasal spray jumped in the fourth quarter last year, priming the pump for a suite of other pharmas, including AbbVie, champing at the bit with their own ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results